Jyong Biotech Ltd. (MENS) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Jyong Biotech Ltd. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Jyong Biotech Ltd. and Tonix Pharmaceuticals Holding Corp. are of similar size ($166.4M and $162.6M). Across the 5 metrics below, Jyong Biotech Ltd. leads on 3 and Tonix Pharmaceuticals Holding Corp. on 2.

Valuation

Metric MENS TNXP Biotechnology median
P/E — n/m 7.88
P/S — 5.64 11.47
P/B n/m 0.74 2.52
Price to free cash flow — n/m 21.16
EV/EBITDA n/m 0.03 0.74
EV/Sales n/m (0.16) 10.73
Earnings yield — (134.34%) (28.84%)
Free cash flow yield — (96.39%) (23.03%)

Profitability

Metric MENS TNXP Biotechnology median
Gross margin — 83.83% 65.16%
Operating margin — (568.43%) 0.00%
Net margin — (548.64%) 0.00%
Free cash flow margin — (543.29%) 0.00%
Return on equity — (81.82%) (57.72%)
Return on assets — (72.34%) (49.22%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric MENS TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 5.64%
EPS growth (last fiscal year) (42.18%) 91.75% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MENS TNXP Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 0.45 6.61 4.73
Net debt to EBITDA (6.89) 1.68 0.96

Dividend

Metric MENS TNXP Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric MENS TNXP Biotechnology median
Market cap 162.57m 166.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack